Results 141 to 150 of about 23,377,083 (210)

The GSEC-encoded polypeptide GESP drives colorectal cancer tumorigenesis via NPM1-c-Myc-mediated repression of NDRG1. [PDF]

Oncogene
Kawasaki Y, Hayashi T, Kitta-Kunihiro A, Negishi L, Suda S, Furuya-Ikude C, Taniguchi N, Akiyama T, Kondo E.   +8 more
europepmc   +1 more source

MAGEC2 promotes tumorigenesis in multiple myeloma through USP16-mediated deubiquitination and stabilization of c-Myc. [PDF]

Exp Hematol Oncol
Liu Z, Hu T, Min J, Wang C, Cao Y, Guo M, Qian J, Gu C, Yang Y.   +8 more
europepmc   +1 more source

Involvement of c-Myc/WWP1/TRIM65 Axis in Renal Fibrosis. [PDF]

Biomolecules
Mazumder S, Gifford C, Tang J, Gaba F, Mondal V, Goldschmeding R, Samarakoon R, Higgins PJ.   +7 more
europepmc   +1 more source

Alterations and interactions: effects of Porphyromonas gingivalis and Bifidobacterium bifidum on c-MYC/CCAT2 gene expression in colorectal cancer. [PDF]

Infect Agent Cancer
Kazemi K, Sameni F, Vaezi AA, Yaslianifard S, Tabaeian SP, MohammadSalehi R, Rafiemanesh H, Atefpour Y, Yadegarynia D, Hajikhani B, Dadashi M.   +10 more
europepmc   +1 more source

Correction: A positive feedback loop between TKT and c-Myc drives TACE resistance in hepatocellular carcinoma. [PDF]

Cell Death Discov
Xiao Y, Liu M, Zhou Y, Bao Y, Zhang G, Xu B, Zheng W, Zhao H.   +7 more
europepmc   +1 more source

CDC20 promotes prostate cancer progression via modulating c-MYC and PI3K-AKT signaling. [PDF]

iScience
Ding J, Xu X, Zhang N, Chen J, Zhu W, Lu K, Wang C, Fu Z, Zhai J, Wang Y.   +9 more
europepmc   +1 more source

Down-regulation of THBS2 inhibits the malignant progression of Burkitt lymphoma by blocking the PI3K/AKT/c-MYC pathway. [PDF]

Front Oncol
Xu Y, Liu S, Wang S, Huang Y.
europepmc   +1 more source

2-O-Methylmagnolol suppresses oral squamous cell carcinoma progression by targeting c-MYC signaling. [PDF]

J Dent Sci
Chen CY, Shieh TM, Chen CC, Leu YL, Chu YD, Liou MJ, Liu YT, Lin HW, Chen KY, Yu CC, Wang TH.   +10 more
europepmc   +1 more source